Karyopharm Therapeutics Inc (KPTI) — Financial Flexibility Index
Karyopharm Therapeutics Inc (KPTI) has a Financial Flexibility Index of -0.06x as of June 2026. Free cash flow of $-24.93 Million (operating CF $-24.93 Million minus capex $0.00) represents 0% of total liabilities ($441.49 Million). Check Karyopharm Therapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Karyopharm Therapeutics Inc Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Karyopharm Therapeutics Inc across 15 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Karyopharm Therapeutics Inc.
Annual Financial Flexibility Index for Karyopharm Therapeutics Inc (2011–2025)
Year-by-year free cash flow to debt coverage for Karyopharm Therapeutics Inc. Explore Karyopharm Therapeutics Inc (KPTI) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.19x | $-75.37 Million | $-75.37 Million | $401.34 Million | ▲ +48.3% |
| 2024 | -0.36x | $-127.34 Million | $-127.49 Million | $350.44 Million | ▼ -47.6% |
| 2023 | -0.25x | $-92.72 Million | $-92.72 Million | $376.64 Million | ▲ +38.3% |
| 2022 | -0.40x | $-149.44 Million | $-149.55 Million | $374.83 Million | ▼ -51.4% |
| 2021 | -0.26x | $-101.40 Million | $-107.12 Million | $384.98 Million | ▲ +56.8% |
| 2020 | -0.61x | $-160.09 Million | $-160.23 Million | $262.50 Million | ▲ +21.6% |
| 2019 | -0.78x | $-190.62 Million | $-190.82 Million | $245.19 Million | ▲ +21.6% |
| 2018 | -0.99x | $-156.75 Million | $-159.12 Million | $158.02 Million | ▲ +31.5% |
| 2017 | -1.45x | $-73.66 Million | $-73.72 Million | $50.83 Million | ▲ +68.8% |
| 2016 | -4.65x | $-84.32 Million | $-84.39 Million | $18.14 Million | ▲ +14.3% |
| 2015 | -5.42x | $-92.61 Million | $-94.03 Million | $17.08 Million | ▼ -51.1% |
| 2014 | -3.59x | $-48.61 Million | $-51.45 Million | $13.54 Million | ▲ +60.9% |
| 2013 | -9.18x | $-30.23 Million | $-30.29 Million | $3.29 Million | ▼ -1642.0% |
| 2012 | -0.53x | $-15.39 Million | $-15.51 Million | $29.19 Million | ▼ -28.2% |
| 2011 | -0.41x | $-8.17 Million | $-8.55 Million | $19.88 Million | — |